https://www.selleckchem.com/products/sr-4835.html
he treatment used, the risk of TLR was lower in BMS- versus DES-ISR (9.7% vs. 17.0%; HR 0.56; 95% CI 0.42 to 0.74), whereas safety was not significantly different between ISR types. Conclusions At 3-year follow-up, DCB angioplasty and repeat stenting with DES are similarly effective and safe in the treatment of BMS-ISR, whereas DCB angioplasty is significantly less effective than repeat DES implantation in the treatment DES-ISR, and associated with a nonsignificant reduction in the primary composite safety endpoint. Overall, DES-ISR is
Like
Comment
Share
